AIM
CC icon

Arcadia Investment Management’s Chemours CC Stock Holding History

Arcadia Investment Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-56
Closed – – 489
2016
Q1 		$0 Hold
56
– – ﹤0.01% 294
2015
Q4 		$0 Buy
+56
New +$358 ﹤0.01% 288

Other funds holding CC

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Arcadia Investment Management's CC Position: Q2 2016 in Review

Arcadia Investment Management sold out of Chemours (CC) in Q2 2016, closing a stake of 56 shares.

Arcadia Investment Management first reported a position in CC in Q4 2015 and held it in 2 quarters. The position peaked at $0 in Q1 2016. 371 funds tracked by Wall St. Rank hold CC as of Q2 2016.

  • Arcadia Investment Management reported no remaining Chemours position as of Q2 2016 after selling out during the quarter.
  • Arcadia Investment Management sold 56 Chemours shares in Q2 2016.
  • Arcadia Investment Management first reported a position in Chemours in Q4 2015 and held it in 2 quarters.
  • Arcadia Investment Management's Chemours position peaked at $0 in Q1 2016.
  • 371 funds tracked by Wall St. Rank held Chemours as of Q2 2016.

Based on Arcadia Investment Management's 13F filing for Q2 2016, filed 15 Jul 2016.